Stuart C. Ray - Publications

Affiliations: 
Johns Hopkins University, Baltimore, MD 
Area:
Immunology, Virology Biology, Cell Biology

121 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Ogega CO, Skinner NE, Schoenle MV, Wilcox XE, Frumento N, Wright DA, Paul HT, Sinnis-Bourozikas A, Clark KE, Figueroa A, Bjorkman PJ, Ray SC, Flyak AI, Bailey JR. Convergent evolution and targeting of diverse E2 epitopes by human broadly neutralizing antibodies are associated with HCV clearance. Immunity. PMID 38518779 DOI: 10.1016/j.immuni.2024.03.001  0.441
2023 Frumento N, Sinnis-Bourozikas A, Paul HT, Stavrakis G, Zahid MN, Wang S, Ray SC, Flyak AI, Shaw GM, Cox AL, Bailey JR. Neutralizing antibodies evolve to exploit vulnerable sites in the HCV envelope glycoprotein E2 and mediate spontaneous clearance of infection. Immunity. PMID 38171362 DOI: 10.1016/j.immuni.2023.12.004  0.481
2023 Liang TJ, Law JLM, Pietschmann T, Ray SC, Bukh J, Bull R, Chung RT, Tyrrell DL, Houghton M, Rice CM. Challenge Inoculum for Hepatitis C Virus Controlled Human Infection Model. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 77: S257-S261. PMID 37579208 DOI: 10.1093/cid/ciad336  0.43
2023 Skinner NE, Ogega CO, Frumento N, Clark KE, Paul H, Yegnasubramanian S, Schuebel K, Meyers J, Gupta A, Wheelan S, Cox AL, Crowe JE, Ray SC, Bailey JR. Corrigendum: Convergent antibody responses are associated with broad neutralization of hepatitis C virus. Frontiers in Immunology. 14: 1201033. PMID 37180140 DOI: 10.3389/fimmu.2023.1201033  0.318
2023 Skinner NE, Ogega CO, Frumento N, Clark KE, Yegnasubramanian S, Schuebel K, Meyers J, Gupta A, Wheelan S, Cox AL, Crowe JE, Ray SC, Bailey JR. Convergent antibody responses are associated with broad neutralization of hepatitis C virus. Frontiers in Immunology. 14: 1135841. PMID 37033983 DOI: 10.3389/fimmu.2023.1135841  0.46
2022 Frumento N, Figueroa A, Wang T, Zahid MN, Wang S, Massaccesi G, Stavrakis G, Crowe JE, Flyak AI, Ji H, Ray SC, Shaw G, Cox AL, Bailey JR. Repeated exposure to heterologous hepatitis C viruses associates with enhanced neutralizing antibody breadth and potency. The Journal of Clinical Investigation. PMID 35588376 DOI: 10.1172/JCI160058  0.448
2022 Ogega CO, Skinner NE, Flyak AI, Clark KE, Board NL, Bjorkman PJ, Crowe JE, Cox AL, Ray SC, Bailey JR. B cell overexpression of FCRL5 and PD-1 is associated with low antibody titers in HCV infection. Plos Pathogens. 18: e1010179. PMID 34990486 DOI: 10.1371/journal.ppat.1010179  0.376
2021 Kandathil AJ, Cox AL, Page K, Mohr D, Razaghi R, Ghanem KG, Tuddenham SA, Hsieh YH, Evans JL, Coller KE, Timp W, Celentano DD, Ray SC, Thomas DL. Plasma virome and the risk of blood-borne infection in persons with substance use disorder. Nature Communications. 12: 6909. PMID 34824209 DOI: 10.1038/s41467-021-26980-8  0.476
2021 Skinner NE, Vergara C, El-Diwany R, Paul H, Skaist A, Wheelan SJ, Thomas DL, Ray SC, Balagopal A, Bailey JR. Decreased Activated CD4 T Cell Repertoire Diversity After Antiretroviral Therapy in HIV-1/HCV Coinfection Correlates with CD4 T Cell Recovery. Viral Immunology. PMID 34672777 DOI: 10.1089/vim.2021.0027  0.311
2021 Clipman SJ, Mehta SH, Rodgers MA, Duggal P, Srikrishnan AK, Saravanan S, Balakrishnan P, Vasudevan CK, Ray SC, Kumar MS, Quinn TC, Cloherty GA, Lucas GM, Solomon SS. Spatiotemporal phylodynamics of hepatitis C among people who inject drugs in India. Hepatology (Baltimore, Md.). PMID 34008172 DOI: 10.1002/hep.31912  0.407
2020 Falade-Nwulia O, Hackman J, Mehta SH, McCormick SD, Kirk GD, Sulkowski M, Thomas D, Latkin C, Laeyendecker O, Ray SC. Factors associated with phylogenetic clustering of hepatitis C among people who inject drugs in Baltimore. Bmc Infectious Diseases. 20: 815. PMID 33167892 DOI: 10.1186/s12879-020-05546-x  0.414
2019 Hackman J, Falade-Nwulia O, Patel EU, Mehta SH, Kirk GD, Astemborski J, Ray SC, Thomas DL, Laeyendecker O. Correlates of hepatitis C viral clustering among people who inject drugs in Baltimore. Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases. 104078. PMID 31669367 DOI: 10.1016/J.Meegid.2019.104078  0.4
2019 Kinchen VJ, Massaccesi G, Flyak AI, Mankowski MC, Colbert MD, Osburn WO, Ray SC, Cox AL, Crowe JE, Bailey JR. Plasma deconvolution identifies broadly neutralizing antibodies associated with hepatitis C virus clearance. The Journal of Clinical Investigation. 130. PMID 31408439 DOI: 10.1172/Jci130720  0.516
2019 Rose R, Rodriguez C, Dollar JJ, Lamers SL, Massaccesi G, Osburn W, Ray SC, Thomas DL, Cox AL, Laeyendecker O. Inconsistent temporal patterns of genetic variation of HCV among high-risk subjects may impact inference of transmission networks. Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases. PMID 30802530 DOI: 10.1016/J.Meegid.2019.02.025  0.509
2019 Hackman J, Falade-Nwulia O, Mehta S, Downing Z, Kirk G, Ray S, Thomas D, Laeyendecker O. A23 Population level diversification of hepatitis C viral strains over time among people who inject drugs in Baltimore, MD Virus Evolution. 5. DOI: 10.1093/Ve/Vez002.022  0.358
2019 Falade-Nwulia O, Hackman J, Mehta S, Sulkowski M, Latkin C, Thomas D, Downing Z, Latanich R, Kirk G, Laeyendecker O, Ray S. A22 Phylogenetic clustering of hepatitis C virus infection among people who inject drugs in Baltimore Virus Evolution. 5. DOI: 10.1093/Ve/Vez002.021  0.549
2018 Kinchen VJ, Zahid MN, Flyak AI, Soliman MG, Learn GH, Wang S, Davidson E, Doranz BJ, Ray SC, Cox AL, Crowe JE, Bjorkman PJ, Shaw GM, Bailey JR. Broadly Neutralizing Antibody Mediated Clearance of Human Hepatitis C Virus Infection. Cell Host & Microbe. 24: 717-730.e5. PMID 30439341 DOI: 10.1016/J.Chom.2018.10.012  0.59
2018 El-Diwany R, Soliman M, Sugawara S, Breitwieser F, Skaist A, Coggiano C, Sangal N, Chattergoon M, Bailey JR, Siliciano RF, Blankson JN, Ray SC, Wheelan SJ, Thomas DL, Balagopal A. CMPK2 and BCL-G are associated with type 1 interferon-induced HIV restriction in humans. Science Advances. 4: eaat0843. PMID 30083606 DOI: 10.1126/Sciadv.Aat0843  0.397
2018 Powell L, Wiederkehr RS, Damascus P, Fauvart M, Buja F, Stakenborg T, Ray SC, Fiorini P, Osburn WO. Rapid and sensitive detection of viral nucleic acids using silicon microchips. The Analyst. PMID 29741175 DOI: 10.1039/C8An00552D  0.316
2018 Wang Z, Gurule EE, Brennan TP, Gerold JM, Kwon KJ, Hosmane NN, Kumar MR, Beg SA, Capoferri AA, Ray SC, Ho YC, Hill AL, Siliciano JD, Siliciano RF. Expanded cellular clones carrying replication-competent HIV-1 persist, wax, and wane. Proceedings of the National Academy of Sciences of the United States of America. PMID 29483265 DOI: 10.1073/Pnas.1720665115  0.465
2017 Mankowski MC, Kinchen VJ, Wasilewski LN, Flyak AI, Ray SC, Crowe JE, Bailey JR. Synergistic anti-HCV broadly neutralizing human monoclonal antibodies with independent mechanisms. Proceedings of the National Academy of Sciences of the United States of America. PMID 29255018 DOI: 10.1073/Pnas.1718441115  0.521
2017 Rose R, Lamers SL, Massaccesi G, Osburn W, Ray SC, Thomas DL, Cox AL, Laeyendecker O. Complex patterns of Hepatitis-C virus longitudinal clustering in a high-risk population. Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases. PMID 29253674 DOI: 10.1016/J.Meegid.2017.12.015  0.393
2017 Tolan NV, Horowitz GL, Graham CS, Hillyard D, Osburn W, Ray S. New Therapies for Treating Hepatitis C Virus: Impact on Laboratory Testing Recommendations and Clinical Management. Clinical Chemistry. PMID 29018029 DOI: 10.1373/Clinchem.2016.266569  0.578
2017 Bailey JR, Flyak AI, Cohen VJ, Li H, Wasilewski LN, Snider AE, Wang S, Learn GH, Kose N, Loerinc L, Lampley R, Cox AL, Pfaff JM, Doranz BJ, Shaw GM, ... Ray SC, et al. Broadly neutralizing antibodies with few somatic mutations and hepatitis C virus clearance. Jci Insight. 2. PMID 28469084 DOI: 10.1172/Jci.Insight.92872  0.543
2017 El-Diwany R, Breitwieser FP, Soliman M, Skaist AM, Srikrishna G, Blankson JN, Ray SC, Wheelan SJ, Thomas DL, Balagopal A. Intracellular HIV-1 rna and CD4+ t cell activation in patients starting antiretrovirals. Aids (London, England). PMID 28358734 DOI: 10.1097/Qad.0000000000001480  0.336
2017 El-Diwany R, Cohen VJ, Mankowski MC, Wasilewski LN, Brady JK, Snider AE, Osburn WO, Murrell B, Ray SC, Bailey JR. Extra-epitopic hepatitis C virus polymorphisms confer resistance to broadly neutralizing antibodies by modulating binding to scavenger receptor B1. Plos Pathogens. 13: e1006235. PMID 28235087 DOI: 10.1371/Journal.Ppat.1006235  0.504
2016 Wasilewski L, Ray S, Bailey JR. Hepatitis C virus resistance to broadly neutralizing antibodies measured using replication competent virus and pseudoparticles. The Journal of General Virology. PMID 27667373 DOI: 10.1099/Jgv.0.000608  0.562
2016 Wasilewski LN, El-Diwany R, Munshaw S, Snider AE, Brady JK, Osburn WO, Ray SC, Bailey JR. A hepatitis C virus envelope polymorphism confers resistance to neutralization by polyclonal sera and broadly neutralizing monoclonal antibodies. Journal of Virology. PMID 26819308 DOI: 10.1128/Jvi.02837-15  0.559
2016 Torimiro J, Tchapda L, Boda M, Bimela J, Netski D, Takou D, Burke D, Tamoufe U, Mpoudi-Ngole E, Luma H, Njoya O, Mbacham W, Wolfe N, Ray S. Hepatitis C Virus Genetic Diversity and Drug Mutational Analysis in Cameroon: 1992 to 2013 British Microbiology Research Journal. 17: 1-10. DOI: 10.9734/Bmrj/2016/28823  0.404
2015 El-Diwany R, Wasilewski L, Witwer KW, Bailey JR, Page K, Ray SC, Cox AL, Thomas DL, Balagopal A. Acute Hepatitis C Virus Infection Induces Consistent Changes in Circulating miRNAs that are Associated with Non-Lytic Hepatocyte Release. Journal of Virology. PMID 26157120 DOI: 10.1128/Jvi.00955-15  0.439
2015 Newman RM, Lamers SL, Weiner B, Ray SC, Colgrove RC, Diaz F, Jing L, Wang K, Saif S, Young S, Henn M, Laeyendecker O, Tobian AA, Cohen JI, Koelle DM, et al. Genome Sequencing and Analysis of Geographically Diverse Clinical Isolates of Herpes Simplex Virus 2. Journal of Virology. 89: 8219-32. PMID 26018166 DOI: 10.1128/Jvi.01303-15  0.325
2015 Lamers SL, Newman RM, Laeyendecker O, Tobian AA, Colgrove RC, Ray SC, Koelle DM, Cohen J, Knipe DM, Quinn TC. Global Diversity within and between Human Herpesvirus 1 and 2 Glycoproteins. Journal of Virology. 89: 8206-18. PMID 26018161 DOI: 10.1128/Jvi.01302-15  0.371
2015 Bailey JR, Dowd KA, Snider AE, Osburn WO, Mehta SH, Kirk GD, Thomas DL, Ray SC. CD4+ T-Cell-Dependent Reduction in Hepatitis C Virus-Specific Neutralizing Antibody Responses After Coinfection With Human Immunodeficiency Virus. The Journal of Infectious Diseases. PMID 25754978 DOI: 10.1093/Infdis/Jiv139  0.775
2015 Bailey JR, Wasilewski LN, Snider AE, El-Diwany R, Osburn WO, Keck Z, Foung SK, Ray SC. Naturally selected hepatitis C virus polymorphisms confer broad neutralizing antibody resistance. The Journal of Clinical Investigation. 125: 437-47. PMID 25500884 DOI: 10.1172/Jci78794  0.532
2015 Ray SC, Thomas DL. 156 – Hepatitis C Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 1904-1927. DOI: 10.1016/B978-1-4557-4801-3.00156-9  0.394
2014 Graw F, Balagopal A, Kandathil AJ, Ray SC, Thomas DL, Ribeiro RM, Perelson AS. Inferring viral dynamics in chronically HCV infected patients from the spatial distribution of infected hepatocytes. Plos Computational Biology. 10: e1003934. PMID 25393308 DOI: 10.1371/Journal.Pcbi.1003934  0.529
2014 Hutchison C, Kwong A, Ray S, Struble K, Swan T, Miller V. Accelerating drug development through collaboration: the Hepatitis C Drug Development Advisory Group. Clinical Pharmacology and Therapeutics. 96: 162-5. PMID 24853733 DOI: 10.1038/Clpt.2014.113  0.464
2014 Balagopal A, Kandathil AJ, Higgins YH, Wood J, Richer J, Quinn J, Eldred L, Li Z, Ray SC, Sulkowski MS, Thomas DL. Antiretroviral therapy, interferon sensitivity, and virologic setpoint in human immunodeficiency virus/hepatitis C virus coinfected patients. Hepatology (Baltimore, Md.). 60: 477-86. PMID 24706559 DOI: 10.1002/Hep.27158  0.571
2014 Grabowski MK, Lessler J, Redd AD, Kagaayi J, Laeyendecker O, Ndyanabo A, Nelson MI, Cummings DA, Bwanika JB, Mueller AC, Reynolds SJ, Munshaw S, Ray SC, Lutalo T, Manucci J, et al. The role of viral introductions in sustaining community-based HIV epidemics in rural Uganda: evidence from spatial clustering, phylogenetics, and egocentric transmission models. Plos Medicine. 11: e1001610. PMID 24595023 DOI: 10.1371/Journal.Pmed.1001610  0.354
2014 Osburn WO, Snider AE, Wells BL, Latanich R, Bailey JR, Thomas DL, Cox AL, Ray SC. Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses. Hepatology (Baltimore, Md.). 59: 2140-51. PMID 24425349 DOI: 10.1002/Hep.27013  0.564
2013 Torimiro JN, Mao Q, Wolfe ND, Tamoufe U, Weil A, Ngole EM, Burke DS, Ray SC, Netski D. Molecular epidemiology of GB type C virus among individuals exposed to hepatitis C virus in Cameroon. Microbiology Research. 4: 1-4. PMID 34178297 DOI: 10.4081/mr.2013.e1  0.438
2013 Kandathil AJ, Graw F, Quinn J, Hwang HS, Torbenson M, Perelson AS, Ray SC, Thomas DL, Ribeiro RM, Balagopal A. Use of laser capture microdissection to map hepatitis C virus-positive hepatocytes in human liver. Gastroenterology. 145: 1404-13.e1-10. PMID 23973767 DOI: 10.1053/J.Gastro.2013.08.034  0.543
2013 Torimiro JN, Mao Q, Wolfe ND, Tamoufe U, Weil A, Mpoudi Ngole E, Burke DS, Ray SC, Netski D. Molecular epidemiology of GB type C virus among individuals exposed to hepatitis C virus in Cameroon Microbiology Research. 4: 1. DOI: 10.4081/Mr.2013.E1  0.526
2012 Bailey JR, Laskey S, Wasilewski LN, Munshaw S, Fanning LJ, Kenny-Walsh E, Ray SC. Constraints on viral evolution during chronic hepatitis C virus infection arising from a common-source exposure. Journal of Virology. 86: 12582-90. PMID 22973048 DOI: 10.1128/Jvi.01440-12  0.583
2012 Burke KP, Munshaw S, Osburn WO, Levine J, Liu L, Sidney J, Sette A, Ray SC, Cox AL. Immunogenicity and cross-reactivity of a representative ancestral sequence in hepatitis C virus infection. Journal of Immunology (Baltimore, Md. : 1950). 188: 5177-88. PMID 22508927 DOI: 10.4049/Jimmunol.1103008  0.504
2012 Munshaw S, Bailey JR, Liu L, Osburn WO, Burke KP, Cox AL, Ray SC. Computational reconstruction of Bole1a, a representative synthetic hepatitis C virus subtype 1a genome. Journal of Virology. 86: 5915-21. PMID 22438535 DOI: 10.1128/Jvi.05959-11  0.551
2012 Munshaw S, Hwang HS, Torbenson M, Quinn J, Hansen KD, Astemborski J, Mehta SH, Ray SC, Thomas DL, Balagopal A. Laser captured hepatocytes show association of butyrylcholinesterase gene loss and fibrosis progression in hepatitis C-infected drug users. Hepatology (Baltimore, Md.). 56: 544-54. PMID 22331678 DOI: 10.1002/Hep.25655  0.522
2012 Liu L, Fisher BE, Thomas DL, Cox AL, Ray SC. Spontaneous clearance of primary acute hepatitis C virus infection correlated with high initial viral RNA level and rapid HVR1 evolution. Hepatology (Baltimore, Md.). 55: 1684-91. PMID 22234804 DOI: 10.1002/Hep.25575  0.56
2012 Sabo MC, Luca VC, Ray SC, Bukh J, Fremont DH, Diamond MS. Hepatitis C virus epitope exposure and neutralization by antibodies is affected by time and temperature. Virology. 422: 174-84. PMID 22078164 DOI: 10.1016/J.Virol.2011.10.023  0.509
2011 Eshleman SH, Hudelson SE, Redd AD, Wang L, Debes R, Chen YQ, Martens CA, Ricklefs SM, Selig EJ, Porcella SF, Munshaw S, Ray SC, Piwowar-Manning E, McCauley M, Hosseinipour MC, et al. Analysis of genetic linkage of HIV from couples enrolled in the HIV Prevention Trials Network 052 trial. The Journal of Infectious Diseases. 204: 1918-26. PMID 21990420 DOI: 10.1093/Infdis/Jir651  0.356
2011 Ng OT, Munshaw S, Lamers SL, Chew KK, Lin L, Redd AD, Manucci J, Quinn TC, Ray SC, Chua A, Leo YS, Laeyendecker O. Molecular epidemiology of HIV type 1 in Singapore and identification of novel CRF01_AE/B recombinant forms. Aids Research and Human Retroviruses. 27: 1135-7. PMID 21235306 DOI: 10.1089/Aid.2010.0364  0.392
2010 Mehta SH, Vogt SL, Srikrishnan AK, Vasudevan CK, Murugavel KG, Saravanan S, Anand S, Kumar MS, Ray SC, Celentano DD, Solomon S, Solomon SS. Epidemiology of hepatitis C virus infection & liver disease among injection drug users (IDUs) in Chennai, India. The Indian Journal of Medical Research. 132: 706-14. PMID 21245619  0.5
2010 Salgado M, Brennan TP, O'Connell KA, Bailey JR, Ray SC, Siliciano RF, Blankson JN. Evolution of the HIV-1 nef gene in HLA-B*57 positive elite suppressors. Retrovirology. 7: 94. PMID 21059238 DOI: 10.1186/1742-4690-7-94  0.403
2010 Towler WI, James MM, Ray SC, Wang L, Donnell D, Mwatha A, Guay L, Nakabiito C, Musoke P, Jackson JB, Eshleman SH. Analysis of HIV diversity using a high-resolution melting assay. Aids Research and Human Retroviruses. 26: 913-8. PMID 20666583 DOI: 10.1089/Aid.2009.0259  0.355
2010 Fletcher NF, Yang JP, Farquhar MJ, Hu K, Davis C, He Q, Dowd K, Ray SC, Krieger SE, Neyts J, Baumert TF, Balfe P, McKeating JA, Wong-Staal F. Hepatitis C virus infection of neuroepithelioma cell lines. Gastroenterology. 139: 1365-74. PMID 20538002 DOI: 10.1053/J.Gastro.2010.06.008  0.747
2010 O'Connell KA, Brennan TP, Bailey JR, Ray SC, Siliciano RF, Blankson JN. Control of HIV-1 in elite suppressors despite ongoing replication and evolution in plasma virus. Journal of Virology. 84: 7018-28. PMID 20444904 DOI: 10.1128/Jvi.00548-10  0.431
2010 Liu L, Fisher BE, Dowd KA, Astemborski J, Cox AL, Ray SC. Acceleration of hepatitis C virus envelope evolution in humans is consistent with progressive humoral immune selection during the transition from acute to chronic infection Journal of Virology. 84: 5067-5077. PMID 20200239 DOI: 10.1128/Jvi.02265-09  0.748
2010 Thio CL, Ray SC, Datta S, Panigrahi R, Biswas A, Chakravarty R. Genetic linkage of hepatitis B virus in peripheral blood leukocytes provides evidence for contamination. Journal of Virology. 84: 2184-6. PMID 20097886 DOI: 10.1128/Jvi.02263-09  0.373
2010 Osburn WO, Fisher BE, Dowd KA, Urban G, Liu L, Ray SC, Thomas DL, Cox AL. Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection. Gastroenterology. 138: 315-24. PMID 19782080 DOI: 10.1053/J.Gastro.2009.09.017  0.755
2009 Fan X, Mao Q, Zhou D, Lu Y, Xing J, Xu Y, Ray SC, Di Bisceglie AM. High diversity of hepatitis C viral quasispecies is associated with early virological response in patients undergoing antiviral therapy. Hepatology (Baltimore, Md.). 50: 1765-72. PMID 19937690 DOI: 10.1002/Hep.23290  0.538
2009 O'Connell KA, Xu J, Durbin AP, Apuzzo LG, Imteyaz H, Williams TM, Ray SC, Margolick JB, Siliciano RF, Blankson JN. HIV-1 evolution following transmission to an HLA-B*5801-positive patient. The Journal of Infectious Diseases. 200: 1820-4. PMID 19909081 DOI: 10.1086/648377  0.426
2009 Balagopal A, Ray SC, De Oca RM, Sutcliffe CG, Vivekanandan P, Higgins Y, Mehta SH, Moore RD, Sulkowski MS, Thomas DL, Torbenson MS. Kupffer cells are depleted with HIV immunodeficiency and partially recovered with antiretroviral immune reconstitution. Aids (London, England). 23: 2397-404. PMID 19773633 DOI: 10.1097/Qad.0B013E3283324344  0.421
2009 Shiu C, Cunningham CK, Greenough T, Muresan P, Sanchez-Merino V, Carey V, Jackson JB, Ziemniak C, Fox L, Belzer M, Ray SC, Luzuriaga K, Persaud D. Identification of ongoing human immunodeficiency virus type 1 (HIV-1) replication in residual viremia during recombinant HIV-1 poxvirus immunizations in patients with clinically undetectable viral loads on durable suppressive highly active antiretroviral therapy. Journal of Virology. 83: 9731-42. PMID 19605490 DOI: 10.1128/Jvi.00570-09  0.496
2009 Wind-Rotolo M, Durand C, Cranmer L, Reid A, Martinson N, Doherty M, Jilek BL, Kagaayi J, Kizza A, Pillay V, Laeyendecker O, Reynolds SJ, Eshleman SH, Lau B, Ray SC, et al. Identification of nevirapine-resistant HIV-1 in the latent reservoir after single-dose nevirapine to prevent mother-to-child transmission of HIV-1. The Journal of Infectious Diseases. 199: 1301-9. PMID 19338474 DOI: 10.1086/597759  0.378
2009 Dowd KA, Netski DM, Wang XH, Cox AL, Ray SC. Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus. Gastroenterology. 136: 2377-86. PMID 19303013 DOI: 10.1053/J.Gastro.2009.02.080  0.711
2008 Hoffman CJ, Ray SC. Severe pruritus after completing pegylated interferon for hepatitis C. The Aids Reader. 18: 562-5. PMID 19062400  0.491
2008 Rutebemberwa A, Ray SC, Astemborski J, Levine J, Liu L, Dowd KA, Clute S, Wang C, Korman A, Sette A, Sidney J, Pardoll DM, Cox AL. High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection. Journal of Immunology (Baltimore, Md. : 1950). 181: 8215-25. PMID 19050238 DOI: 10.4049/Jimmunol.181.12.8215  0.745
2008 Wölfl M, Rutebemberwa A, Mosbruger T, Mao Q, Li HM, Netski D, Ray SC, Pardoll D, Sidney J, Sette A, Allen T, Kuntzen T, Kavanagh DG, Kuball J, Greenberg PD, et al. Hepatitis C virus immune escape via exploitation of a hole in the T cell repertoire. Journal of Immunology (Baltimore, Md. : 1950). 181: 6435-46. PMID 18941234 DOI: 10.4049/Jimmunol.181.9.6435  0.511
2008 Dowd KA, Hershow RC, Yawetz S, Larussa P, Diaz C, Landesman SH, Paul ME, Read JS, Lu M, Thomas DL, Netski DM, Ray SC. Maternal neutralizing antibody and transmission of hepatitis C virus to infants. The Journal of Infectious Diseases. 198: 1651-5. PMID 18928374 DOI: 10.1086/593067  0.743
2008 Netski DM, Mao Q, Ray SC, Klein RS. Genetic divergence of hepatitis C virus: the role of HIV-related immunosuppression. Journal of Acquired Immune Deficiency Syndromes (1999). 49: 136-41. PMID 18769357 DOI: 10.1097/Qai.0B013E3181869A6F  0.593
2008 Maheshwari A, Ray S, Thuluvath PJ. Acute hepatitis C The Lancet. 372: 321-332. PMID 18657711 DOI: 10.1016/S0140-6736(08)61116-2  0.557
2008 Bailey JR, O'Connell K, Yang HC, Han Y, Xu J, Jilek B, Williams TM, Ray SC, Siliciano RF, Blankson JN. Transmission of human immunodeficiency virus type 1 from a patient who developed AIDS to an elite suppressor. Journal of Virology. 82: 7395-410. PMID 18495769 DOI: 10.1128/Jvi.00800-08  0.449
2008 Agwu A, Lindsey JC, Ferguson K, Zhang H, Spector S, Rudy BJ, Ray SC, Douglas SD, Flynn PM, Persaud D. Analyses of HIV-1 drug-resistance profiles among infected adolescents experiencing delayed antiretroviral treatment switch after initial nonsuppressive highly active antiretroviral therapy Aids Patient Care and Stds. 22: 545-552. PMID 18479228 DOI: 10.1089/Apc.2007.0200  0.407
2008 Balagopal A, Philp FH, Astemborski J, Block TM, Mehta A, Long R, Kirk GD, Mehta SH, Cox AL, Thomas DL, Ray SC. Human immunodeficiency virus-related microbial translocation and progression of hepatitis C. Gastroenterology. 135: 226-33. PMID 18457674 DOI: 10.1053/J.Gastro.2008.03.022  0.443
2008 Vivekanandan P, Kannangai R, Ray SC, Thomas DL, Torbenson M. Comprehensive genetic and epigenetic analysis of occult hepatitis B from liver tissue samples. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 46: 1227-36. PMID 18444860 DOI: 10.1086/529437  0.423
2008 Andrade A, Bailey JR, Xu J, Philp FH, Quinn TC, Williams TM, Ray SC, Thomas DL, Blankson JN. CD4+ T cell depletion in an untreated HIV type 1-infected human leukocyte antigen-B*5801-positive patient with an undetectable viral load. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 46: e78-82. PMID 18444844 DOI: 10.1086/529387  0.427
2007 Persaud D, Palumbo P, Ziemniak C, Chen J, Ray SC, Hughes M, Havens P, Purswani M, Gaur AH, Chadwick EG. Early archiving and predominance of nonnucleoside reverse transcriptase inhibitor-resistant HIV-1 among recently infected infants born in the United States. The Journal of Infectious Diseases. 195: 1402-10. PMID 17436219 DOI: 10.1086/513871  0.393
2007 Persaud D, Ray SC, Kajdas J, Ahonkhai A, Siberry GK, Ferguson K, Ziemniak C, Quinn TC, Casazza JP, Zeichner S, Gange SJ, Watson DC. Slow human immunodeficiency virus type 1 evolution in viral reservoirs in infants treated with effective antiretroviral therapy. Aids Research and Human Retroviruses. 23: 381-90. PMID 17411371 DOI: 10.1089/Aid.2006.0175  0.434
2007 Wang XH, Netski DM, Astemborski J, Mehta SH, Torbenson MS, Thomas DL, Ray SC. Progression of fibrosis during chronic hepatitis C is associated with rapid virus evolution. Journal of Virology. 81: 6513-22. PMID 17329332 DOI: 10.1128/Jvi.02276-06  0.559
2006 Ziemniak C, George-Agwu A, Moss WJ, Ray SC, Persaud D. A sensitive genotyping assay for detection of drug resistance mutations in reverse transcriptase of HIV-1 subtypes B and C in samples stored as dried blood spots or frozen RNA extracts. Journal of Virological Methods. 136: 238-47. PMID 16828172 DOI: 10.1016/J.Jviromet.2006.05.030  0.406
2006 Bailey JR, Sedaghat AR, Kieffer T, Brennan T, Lee PK, Wind-Rotolo M, Haggerty CM, Kamireddi AR, Liu Y, Lee J, Persaud D, Gallant JE, Cofrancesco J, Quinn TC, Wilke CO, ... Ray SC, et al. Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells. Journal of Virology. 80: 6441-57. PMID 16775332 DOI: 10.1128/Jvi.00591-06  0.397
2006 Bailey JR, Lassen KG, Yang HC, Quinn TC, Ray SC, Blankson JN, Siliciano RF. Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy. Journal of Virology. 80: 4758-70. PMID 16641269 DOI: 10.1128/Jvi.80.10.4758-4770.2006  0.446
2005 Netski DM, Mosbruger T, Depla E, Maertens G, Ray SC, Hamilton RG, Roundtree S, Thomas DL, McKeating J, Cox A. Humoral immune response in acute hepatitis C virus infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 41: 667-75. PMID 16080089 DOI: 10.1086/432478  0.539
2005 Cox AL, Mosbruger T, Lauer GM, Pardoll D, Thomas DL, Ray SC. Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C. Hepatology (Baltimore, Md.). 42: 104-12. PMID 15962289 DOI: 10.1002/Hep.20749  0.54
2005 Ray SC, Fanning L, Wang XH, Netski DM, Kenny-Walsh E, Thomas DL. Divergent and convergent evolution after a common-source outbreak of hepatitis C virus. The Journal of Experimental Medicine. 201: 1753-9. PMID 15939791 DOI: 10.1084/Jem.20050122  0.569
2005 Cox AL, Mosbruger T, Mao Q, Liu Z, Wang XH, Yang HC, Sidney J, Sette A, Pardoll D, Thomas DL, Ray SC. Cellular immune selection with hepatitis C virus persistence in humans. The Journal of Experimental Medicine. 201: 1741-52. PMID 15939790 DOI: 10.1084/Jem.20050121  0.542
2005 Cox AL, Netski DM, Mosbruger T, Sherman SG, Strathdee S, Ompad D, Vlahov D, Chien D, Shyamala V, Ray SC, Thomas DL. Prospective evaluation of community-acquired acute-phase hepatitis C virus infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 40: 951-8. PMID 15824985 DOI: 10.1086/428578  0.57
2005 Monie D, Simmons RP, Nettles RE, Kieffer TL, Zhou Y, Zhang H, Karmon S, Ingersoll R, Chadwick K, Zhang H, Margolick JB, Quinn TC, Ray SC, Wind-Rotolo M, Miller M, et al. A novel assay allows genotyping of the latent reservoir for human immunodeficiency virus type 1 in the resting CD4+ T cells of viremic patients. Journal of Virology. 79: 5185-202. PMID 15795302 DOI: 10.1128/Jvi.79.8.5185-5202.2005  0.414
2005 Laeyendecker O, Zhang GW, Quinn TC, Garten R, Ray SC, Lai S, Liu W, Chen J, Yu XF. Molecular epidemiology of HIV-1 subtypes in southern China. Journal of Acquired Immune Deficiency Syndromes (1999). 38: 356-62. PMID 15735457  0.338
2005 Nettles RE, Kieffer TL, Kwon P, Monie D, Han Y, Parsons T, Cofrancesco J, Gallant JE, Quinn TC, Jackson B, Flexner C, Carson K, Ray S, Persaud D, Siliciano RF. Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART. Jama. 293: 817-29. PMID 15713771 DOI: 10.1001/Jama.293.7.817  0.392
2005 Li K, Foy E, Ferreon JC, Nakamura M, Ferreon AC, Ikeda M, Ray SC, Gale M, Lemon SM. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proceedings of the National Academy of Sciences of the United States of America. 102: 2992-7. PMID 15710891 DOI: 10.1073/Pnas.0408824102  0.442
2005 Kieffer TL, Kwon P, Nettles RE, Han Y, Ray SC, Siliciano RF. G-->A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo. Journal of Virology. 79: 1975-80. PMID 15650227 DOI: 10.1128/Jvi.79.3.1975-1980.2005  0.405
2004 Liu Z, Netski DM, Mao Q, Laeyendecker O, Ticehurst JR, Wang XH, Thomas DL, Ray SC. Accurate representation of the hepatitis C virus quasispecies in 5.2-kilobase amplicons. Journal of Clinical Microbiology. 42: 4223-9. PMID 15365015 DOI: 10.1128/Jcm.42.9.4223-4229.2004  0.566
2004 Kieffer TL, Finucane MM, Nettles RE, Quinn TC, Broman KW, Ray SC, Persaud D, Siliciano RF. Genotypic analysis of HIV-1 drug resistance at the limit of detection: virus production without evolution in treated adults with undetectable HIV loads. The Journal of Infectious Diseases. 189: 1452-65. PMID 15073683 DOI: 10.1086/382488  0.434
2004 Lanford RE, Guerra B, Chavez D, Bigger C, Brasky KM, Wang XH, Ray SC, Thomas DL. Cross-genotype immunity to hepatitis C virus. Journal of Virology. 78: 1575-81. PMID 14722311 DOI: 10.1128/Jvi.78.3.1575-1581.2004  0.546
2004 Persaud D, Siberry GK, Ahonkhai A, Kajdas J, Monie D, Hutton N, Watson DC, Quinn TC, Ray SC, Siliciano RF. Continued production of drug-sensitive human immunodeficiency virus type 1 in children on combination antiretroviral therapy who have undetectable viral loads. Journal of Virology. 78: 968-79. PMID 14694128 DOI: 10.1128/Jvi.78.2.968-979.2004  0.429
2003 Wilbe K, Salminen M, Laukkanen T, McCutchan F, Ray SC, Albert J, Leitner T. Characterization of novel recombinant HIV-1 genomes using the branching index. Virology. 316: 116-25. PMID 14599796 DOI: 10.1016/J.Virol.2003.08.004  0.386
2002 Ruff CT, Ray SC, Kwon P, Zinn R, Pendleton A, Hutton N, Ashworth R, Gange S, Quinn TC, Siliciano RF, Persaud D. Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure. Journal of Virology. 76: 9481-92. PMID 12186930 DOI: 10.1128/Jvi.76.18.9481-9492.2002  0.463
2002 Mehta SH, Cox A, Hoover DR, Wang XH, Mao Q, Ray S, Strathdee SA, Vlahov D, Thomas DL. Protection against persistence of hepatitis C. Lancet (London, England). 359: 1478-83. PMID 11988247 DOI: 10.1016/S0140-6736(02)08435-0  0.546
2002 Sulkowski MS, Ray SC, Thomas DL. Needlestick transmission of hepatitis C. Jama. 287: 2406-13. PMID 11988061 DOI: 10.1001/Jama.287.18.2406  0.565
2001 Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV. Determinants of viral clearance and persistence during acute hepatitis C virus infection Journal of Experimental Medicine. 194: 1395-1406. PMID 11714747 DOI: 10.1084/Jem.194.10.1395  0.556
2001 Wilson LE, Umemura T, Astemborski J, Ray SC, Alter HJ, Strathdee SA, Vlahov D, Thomas DL. Dynamics of SEN virus infection among injection drug users. The Journal of Infectious Diseases. 184: 1315-9. PMID 11679921 DOI: 10.1086/324001  0.384
2001 Hermankova M, Ray SC, Ruff C, Powell-Davis M, Ingersoll R, D'Aquila RT, Quinn TC, Siliciano JD, Siliciano RF, Persaud D. HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy. Jama. 286: 196-207. PMID 11448283 DOI: 10.1001/Jama.286.2.196  0.421
2001 Mao Q, Ray SC, Laeyendecker O, Ticehurst JR, Strathdee SA, Vlahov D, Thomas DL. Human immunodeficiency virus seroconversion and evolution of the hepatitis C virus quasispecies Journal of Virology. 75: 3259-3267. PMID 11238852 DOI: 10.1128/Jvi.75.7.3259-3267.2001  0.59
2000 Nousbaum J, Polyak SJ, Ray SC, Sullivan DG, Larson AM, Carithers RL, Gretch DR. Prospective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapy. Journal of Virology. 74: 9028-38. PMID 10982347 DOI: 10.1128/Jvi.74.19.9028-9038.2000  0.526
2000 Ray SC, Arthur RR, Carella A, Bukh J, Thomas DL. Genetic epidemiology of hepatitis C virus throughout egypt. The Journal of Infectious Diseases. 182: 698-707. PMID 10950762 DOI: 10.1086/315786  0.508
2000 Persaud D, Pierson T, Ruff C, Finzi D, Chadwick KR, Margolick JB, Ruff A, Hutton N, Ray S, Siliciano RF. A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children. The Journal of Clinical Investigation. 105: 995-1003. PMID 10749578 DOI: 10.1172/Jci9006  0.422
2000 Thomas DL, Astemborski J, Vlahov D, Strathdee SA, Ray SC, Nelson KE, Galai N, Nolt KR, Laeyendecker O, Todd JA. Determinants of the quantity of hepatitis C virus RNA Journal of Infectious Diseases. 181: 844-851. PMID 10720503 DOI: 10.1086/315314  0.523
2000 Ray SC, Mao Q, Lanford RE, Bassett S, Laeyendecker O, Wang YM, Thomas DL. Hypervariable region 1 sequence stability during hepatitis C virus replication in chimpanzees Journal of Virology. 74: 3058-3066. PMID 10708420 DOI: 10.1128/Jvi.74.7.3058-3066.2000  0.514
2000 Ray SC, Quinn TC. Sex and the genetic diversity of HIV-1. Nature Medicine. 6: 23-25. PMID 10613817 DOI: 10.1038/71487  0.372
1999 Ray SC, Wang YM, Laeyendecker O, Ticehurst JR, Villano SA, Thomas DL. Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: Hypervariable region 1 as a decoy Journal of Virology. 73: 2938-2946. PMID 10074143 DOI: 10.1128/Jvi.73.4.2938-2946.1999  0.499
1999 Dibbern DA, Ray SC. Recrudescence of treated neurosyphilis in a patient with human immunodeficiency virus. Mayo Clinic Proceedings. 74: 53-6. PMID 9987533 DOI: 10.4065/74.1.53  0.383
1999 Echavarria MS, Ray SC, Ambinder R, Dumler JS, Charache P. PCR detection of adenovirus in a bone marrow transplant recipient: Hemorrhagic cystitis as a presenting manifestation of disseminated disease Journal of Clinical Microbiology. 37: 686-689. PMID 9986832 DOI: 10.1128/Jcm.37.3.686-689.1999  0.376
1999 Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS, Novak NG, Ingersoll R, Sheppard HW, Ray SC. Full-Length Human Immunodeficiency Virus Type 1 Genomes from Subtype C-Infected Seroconverters in India, with Evidence of Intersubtype Recombination Journal of Virology. 73: 152-160. PMID 9847317 DOI: 10.1128/Jvi.73.1.152-160.1999  0.452
1998 Wang YM, Ray SC, Laeyendecker O, Ticehurst JR, Thomas DL. Assessment of hepatitis C virus sequence complexity by electrophoretic mobilities of both single- and double-stranded DNAs Journal of Clinical Microbiology. 36: 2982-2989. PMID 9738054 DOI: 10.1128/Jcm.36.10.2982-2989.1998  0.455
1998 Ray SC, Lubaki N, Dhruva BR, Siliciano RF, Bollinger RC. Autologous strain-specific cytolytic T lymphocyte responses directed against human immunodeficiency virus type 1 Env Aids Research and Human Retroviruses. 14: 3-13. PMID 9453246 DOI: 10.1089/Aid.1998.14.3  0.405
1997 Lubaki NM, Ray SC, Dhruva B, Quinn TC, Siliciano RF, Bollinger RC. Characterization of a polyclonal cytolytic T lymphocyte response to human immunodeficiency virus in persons without clinical progression Journal of Infectious Diseases. 175: 1360-1367. PMID 9180175 DOI: 10.1086/516468  0.413
1996 Schwartz DH, Viscidi R, Laeyendecker O, Song H, Ray SC, Michael N. Predominance of defective proviral sequences in an HIV + long-term non-progressor. Immunology Letters. 51: 3-6. PMID 8811337 DOI: 10.1016/0165-2478(96)02547-3  0.411
1995 Markham RB, Yu X, Farzadegan H, Ray SC, Vlahov D. Human immunodeficiency virus type 1 env and p17gag sequence variation in polymerase chain reaction-positive, seronegative injection drug users. The Journal of Infectious Diseases. 171: 797-804. PMID 7706805 DOI: 10.1093/Infdis/171.4.797  0.445
1995 Strunnikova N, Ray SC, Livingston RA, Rubalcaba E, Viscidi RP. Convergent evolution within the V3 loop domain of human immunodeficiency virus type 1 in association with disease progression. Journal of Virology. 69: 7548-7558. PMID 7494261 DOI: 10.1128/Jvi.69.12.7548-7558.1995  0.431
1994 Baskar PV, Ray SC, Rao R, Quinn TC, Hildreth JEK, Bollinger RC. Presence in India of HIV type 1 similar to North American strains Aids Research and Human Retroviruses. 10: 1039-1041. PMID 7811535 DOI: 10.1089/Aid.1994.10.1039  0.375
Show low-probability matches.